Di Cesare, A., Rosi, E., Trovato, E., Pescitelli, L., Panduri, S., Manzo Margiotta, F., Michelucci, A., Capalbo, E., Dragotto, M., Magnano, M. ., Rossari, S., Savarese, I., Buggiani, G., Milanesi, N., Lorenzoni, E., Ricceri, F., Romanelli, M., Rubegni, P., Pimpinelli, N., & Prignano, F. (2025). Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective Study. Dermatology Practical & Conceptual, 15(4), 5733. https://doi.org/10.5826/dpc.1504a5733